LINC02219: A Long Intergenic Non-Protein Coding RNA (G102467655)

Target Name: LINC02219

NCBI ID: G102467655

LINC02219

Other Name(s): long intergenic non-protein coding RNA 2219 | Long intergenic non-protein coding RNA 2219

LINC02219: A Long Intergenic Non-Protein Coding RNA

LINC02219 is a long non-coding RNA (lncRNA) that has been identified in various studies as having important roles in various biological processes. It is a non-coding RNA molecule that is derived from introns of coding genes, and its function is not well understood. LINC02219 is one of the many non-coding RNAs that have been identified as potential drug targets or biomarkers. In this article, we will explore the potential implications of LINC02219 as a drug target and its potential as a biomarker.

Potential Drug Target

LINC02219 has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and transcriptional regulation. It is also known to interact with several protein substrates, including KLF, IDH1, and Myb. These interactions suggest that LINC02219 may be a useful drug target for the treatment of various diseases.

One of the potential drug targets for LINC02219 is cancer. Cancer is a disease that is characterized by the uncontrolled growth and proliferation of cells. LINC02219 has been shown to promote the growth and survival of various cancer cell types, including human breast cancer cells. Therefore, LINC02219 may be a useful target for the development of cancer therapies that target its expression.

Another potential drug target for LINC02219 is neurodegenerative diseases. LINC02219 has been shown to be involved in the regulation of neurotransmitter synthesis and release, as well as the modulation of neural activity. Therefore, LINC02219 may be a useful target for the development of neurodegenerative disease therapies that target its expression.

Potential Biomarker

LINC02219 may also be a useful biomarker for the diagnosis and monitoring of various diseases. Its expression has been shown to be regulated in a variety of biological processes, including cell growth, apoptosis, and transcriptional regulation. Therefore, changes in LINC02219 expression levels may be informative for the diagnosis and monitoring of various diseases.

One potential application of LINC02219 as a biomarker is for the diagnosis of neurodegenerative diseases. LINC02219 has been shown to be involved in the regulation of neurotransmitter synthesis and release, as well as the modulation of neural activity. Therefore, changes in LINC02219 expression levels may be informative for the diagnosis and monitoring of neurodegenerative diseases.

Another potential application of LINC02219 as a biomarker is for the diagnosis of cancer. LINC02219 has been shown to promote the growth and survival of various cancer cell types, including human breast cancer cells. Therefore, changes in LINC02219 expression levels may be informative for the diagnosis and monitoring of various cancers.

Conclusion

LINC02219 is a long non-coding RNA molecule that has been shown to play important roles in various biological processes. Its function is not well understood, but its potential as a drug target or biomarker is being investigated. Further studies are needed to fully understand the role of LINC02219 in these processes and its potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2219

The "LINC02219 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02219 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets